The U.S. Food and Drug Administration (FDA) has approved Siemens Healthcare’s 3-D mammography, breast tomosynthesis imaging system. This marks the 3-D mammography vendor to enter the U.S. market. 

Hitachi Aloka Medical America, Inc. (HAMA) announced the launch of its new website. Hitachi Aloka Medical America, Inc. which is committed to delivering advanced diagnostic ultrasound systems and solutions to meet the needs of physicians and patients in the USA and Canada has just completed and released a new and improved website with these advanced features:

3D Systems announced that a 20-month-old toddler is breathing and swallowing easier thanks to a team of cardiologists and cardiothoracic surgeons at Washington University School of Medicine in St. Louis. The team used a full-color 3-D printed replica of his heart to prepare for a delicate, 2.5-hour procedure at St. Louis Children's Hospital.

Carestream earned the top rating in MD Buyline’s Market Intelligence Briefing (2015 Q1) for both portable and room-based digital radiography (DR) systems. The company’s DRX-Revolution mobile X-ray system and its DRX-Evolution and DRX-Ascend systems earned high marks from customers for system performance, reliability, installation and service repair quality. The DRX-Revolution was the highest rated portable system and Carestream’s DRX room-based platform tied for the highest rating in the DR room category.

Although ultrasound remains the primary imaging modality used in prenatal imaging, fetal magnetic resonance imaging (MRI) is playing an increasing role in further evaluation of fetuses suspected of congenital anomalies. As 3-T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3-T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.

Ten abstracts on the uses of volumetric breast imaging data were presented at the 2015 European Congress of Radiology (ECR) meeting, focusing on reducing subjectivity in density and assessment and improving breast cancer risk prediction models.

IBA (Ion Beam Applications S.A.) announced that it has signed a formal contract with the University Medical Center Groningen (UMCG) to establish The Netherlands’ first proton therapy center in Groningen.

Recognizing that both women and their doctors are often confused after a mammogram reveals the woman has dense breasts, a nonprofit organization has launched a major new educational website. The site, www.DenseBreast-info.org, addresses questions women and their healthcare providers often have about breast density – helping them to "Get Smart about Being Dense."

Hologic, Inc. issued the following statement today on the draft 2015 guidelines for breast cancer screening published this week by the U.S. Preventive Services Task Force (USPSTF).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now